Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Manulife Financial Corporation (MFC) Stock Forecast & Price Prediction Canada | NYSE | Financial Services | Insurance - Life
$38.81
+0.18 (0.47%)Did MFC Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Manulife is one of their latest high-conviction picks.
Based on our analysis of 7 Wall Street analysts, MFC has a bullish consensus with a median price target of $34.68 (ranging from $31.38 to $37.98). The overall analyst rating is Buy (7.9/10). Currently trading at $38.81, the median forecast implies a -10.6% downside. This outlook is supported by 10 Buy, 3 Hold, and 2 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MFC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 14, 2025 | RBC Capital | Darko Mihelic | Outperform | Maintains | $52.00 |
| Aug 8, 2025 | RBC Capital | Darko Mihelic | Outperform | Maintains | $49.00 |
| Feb 21, 2025 | RBC Capital | Darko Mihelic | Outperform | Maintains | $51.00 |
| Jun 28, 2024 | TD Securities | Mario Mendonca | Buy | Maintains | $40.00 |
| Feb 15, 2024 | BMO Capital | Tom MacKinnon | Outperform | Upgrade | $35.00 |
| Aug 11, 2023 | Barclays | John Aiken | Overweight | Maintains | $33.00 |
| Feb 17, 2023 | RBC Capital | Darko Mihelic | Sector Perform | Maintains | $28.00 |
| Jul 27, 2022 | Scotiabank | Meny Grauman | Sector Outperform | Upgrade | $N/A |
| Aug 10, 2021 | Credit Suisse | Neutral | Downgrade | $N/A | |
| Jan 13, 2020 | Barclays | Overweight | Maintains | $32.00 | |
| Jul 11, 2018 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $26.00 |
| Jul 10, 2018 | Evercore ISI Group | In-Line | Initiates | $N/A | |
| Apr 5, 2018 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $27.00 |
| Feb 22, 2018 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $28.00 |
| Nov 13, 2017 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $28.00 |
| Oct 5, 2017 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $27.00 |
| Sep 21, 2016 | Dundee | Buy | Initiates | $N/A | |
| Aug 24, 2016 | B of A Securities | Buy | Initiates | $N/A | |
| Aug 24, 2016 | Bank of America | Buy | Initiates | $N/A | |
| Aug 4, 2016 | CIBC | Sector Perform | Downgrade | $N/A |
The following stocks are similar to Manulife based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Manulife Financial Corporation has a market capitalization of $64.90B with a P/E ratio of 17.3x. The company generates $22.60B in trailing twelve-month revenue with a 18.7% profit margin.
Revenue growth is -34.9% quarter-over-quarter, while maintaining an operating margin of +133.5% and return on equity of +11.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Multinational insurance and financial services provider.
The company generates revenue by offering a wide range of financial protection and wealth management products, including life insurance, health insurance, annuities, mutual funds, and banking services to individuals and institutions. It operates in several key markets, notably Canada, the United States, and Asia, where it serves a growing demand for life insurance and asset management.
Manulife is recognized for its strong balance sheet and diversified offerings, which enhance its resilience in the financial market. The company focuses on leveraging technology and innovation to provide customer-centric solutions and maintain competitive advantages.
Financial Services
Insurance - Life
37,000
Mr. Philip James Witherington CPA
Canada
1999
Sun Life Financial stock gains from growing asset management businesses, its focus on Asia operations, as well as scaling up and integrating U.S. operations.
Voya Financial stock gains from earnings growth driven by Retirement, Investment Management and Employee Benefits strength, plus disciplined capital deployment, despite leverage concerns.
Cellnex is negotiating to sell its Swiss unit stake to Manulife Financial Corporation's investment management unit, according to sources.
Cellnex's potential sale of its Swiss unit to Manulife could impact its financial position and strategic focus, influencing stock performance and investor sentiment in telecom infrastructure.
Manulife Financial's stock has risen due to strong performance in its Asia business, growth in Wealth and Asset Management, and a robust capital position.
Manulife's stock rise signals confidence in its Asia growth, wealth management expansion, and robust capital, indicating potential for increased profitability and investor returns.
Manulife Investment Management launched the Manulife CQS Multi Asset Credit Fund ETF Series (TSX: MMAC) on April 6, 2026, marking a new addition to the Toronto Stock Exchange.
The launch of the Manulife CQS Multi Asset Credit Fund ETF expands investment options on the TSX, potentially increasing demand and impacting market performance in credit-focused assets.
Zacks emphasizes its Rank system based on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends for investment insights.
The emphasis on earnings estimates and revisions indicates potential stock performance, guiding investors toward high-potential picks based on current market trends.
The April 2026 GASV list features 14 fair-priced mid-to-large-cap value stocks, expected to yield average net gains of 43.98% by April 2027, with dividends between 7.47% and 13.59%.
The GASV list identifies attractive value stocks with strong dividends and significant projected gains, highlighting potential opportunities for income and capital appreciation in the market.
Manulife (MFC) is being evaluated for its potential as a strong dividend stock, highlighting the challenges investors face in identifying quality dividend-paying shares.
Manulife's potential as a dividend stock affects its attractiveness to income-focused investors, impacting demand and share price.
Based on our analysis of 7 Wall Street analysts, Manulife Financial Corporation (MFC) has a median price target of $34.68. The highest price target is $37.98 and the lowest is $31.38.
According to current analyst ratings, MFC has 10 Buy ratings, 3 Hold ratings, and 2 Sell ratings. The stock is currently trading at $38.81. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict MFC stock could reach $34.68 in the next 12 months. This represents a -10.6% decrease from the current price of $38.81. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by offering a wide range of financial protection and wealth management products, including life insurance, health insurance, annuities, mutual funds, and banking services to individuals and institutions. It operates in several key markets, notably Canada, the United States, and Asia, where it serves a growing demand for life insurance and asset management.
The highest price target for MFC is $37.98 from at , which represents a -2.1% decrease from the current price of $38.81.
The lowest price target for MFC is $31.38 from at , which represents a -19.2% decrease from the current price of $38.81.
The overall analyst consensus for MFC is bullish. Out of 7 Wall Street analysts, 10 rate it as Buy, 3 as Hold, and 2 as Sell, with a median price target of $34.68.
Stock price projections, including those for Manulife Financial Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.